Trials / Completed
CompletedNCT02637232
Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE)
Mirvaso® Utilisation and Patient Satisfaction Evaluation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 301 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate the level of satisfaction among patients to whom Mirvaso® / Onreltea TM (trade mark) is prescribed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Mirvaso® / Onreltea TM |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2015-12-22
- Last updated
- 2021-05-28
- Results posted
- 2021-05-28
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02637232. Inclusion in this directory is not an endorsement.